Acute STROke Complicating TAVI - Management and Outcomes (ASTRO-TAVI)

Clalit Health Services

Status: Completed

Conditions: Aortic Valve Stenosis; Stroke; Periprocedural Complication

Treatments: Procedure: Mechanical thrombectomy; Drug: Thrombolytic Agent

Study type: Observational

Funder types: Other

Identifiers

NCT05241821

0502-21

Details and patient eligibility

About

Periprocedural complications of trans catheter aortic valve implantation, and particularly the occurrence of stroke has a marked impact on survival and quality of life. The characteristics of periprocedural stroke complicating TAVI, and particularly of interventions aimed to treat stroke complicating TAVI have not been systematically described. We therefore aimed is to explore the incidence and characteristics of acute stroke complicating TAVI and to describe the safety and efficacy of emergent interventions to treat acute stroke complicating TAVI.

Enrollment: 484 patients

Sex: All

Ages: 18 to 120 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• patients who have had a stroke within 30 days of TAVI

Exclusion criteria

• none

Trial design

484 participants in 2 patient groups

Conservative treatment

Description:

patients with periprocedural stroke after TAVI, treated conservatively

Neuro-intervention

Description:

patients with periprocedural stroke after TAVI, treated with neuro-intervention

Treatment:

Procedure: Mechanical thrombectomy

Drug: Thrombolytic Agent